Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2, Multicenter, 2-part, Open-label Trial to Evaluate DS-3939a in Participants With Solid Tumors

NCT07739966 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT07739966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07739966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2, Multicenter, 2-part, Open-label Trial to Evaluate DS-3939a in Participants With Solid Tumors
Lead sponsor
Daiichi Sankyo
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
January 29, 2032
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced non-small cell lung cancer, metastatic non-small cell lung cancer, solid tumor